Stockreport

Inovio Receives $8.14 Million Award to Support Further Development of its Commercial Skin Delivery Device

Inovio Pharmaceuticals, Inc.  (INO) 
NASDAQ:AMEX Investor Relations: ir.inovio.com/investors/default.aspx
PDF PLYMOUTH MEETING, Pa., June 10, 2019 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced today that the medical arm of the U.S. Defense Threat Reduction [Read more]